Bridgeway Capital Management, LLC 4 D Molecular Therapeutics, Inc. Transaction History

Bridgeway Capital Management, LLC

  • $4.44 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$9.76 - $21.25 $97,600 - $212,500
-10,000 Reduced 36.5%
17,400 $352,000
Q1 2023

May 15, 2023
SELL
$15.45 - $23.19 $231,750 - $347,850
-15,000 Reduced 35.38%
27,400 $471,000
Q4 2022

Feb 14, 2023
SELL
$6.85 - $25.46 $102,750 - $381,900
-15,000 Reduced 26.13%
42,400 $941,000
Q3 2022

Nov 14, 2022
BUY
$6.96 - $11.48 $399,504 - $658,952
57,400 New
57,400 $461,000

Others Institutions Holding FDMT

# of Institutions
144
Shares Held
57.7M
Call Options Held
137K
Put Options Held
111K
View Full List

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $252M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email